feed,title,long_url,short_url
MX,Trial finds that adagrasib demonstrates durable clinical activity in patients with KRAS-G12C mutations,https://medicalxpress.com/news/2023-09-trial-adagrasib-durable-clinical-patients.html,https://da.gd/FYeY
